Find hypoglycemic proprietary market Highlights
National Development and Reform Commission issued on February 28 the adjustment of 278 kinds of proprietary Chinese medicine drug retail price of the program was officially on March 15 execution. This is the price adjustment of proprietary Chinese medicines in China in recent years, the largest one, cut prices was mainly targeted at the clinical use of more share of the larger categories, involving more than 1,000 dosage forms specifications. In addition to cheap drug prices remain unchanged, other specifications of about 70% of the category are the reduction, the average price cut of 15%, the biggest price cut by more than 80%.
Industry has taken note of the National Development and Reform Commission in 2006, Year 3 use classification introduced by pharmaceutical price adjustment measures, this year has reduced by two successive rounds of drug price, price adjustment will only last 3 to 664 kinds of drugs involved . We can clearly see the country the idea of drug price cuts: Given the current health system in China and the market liquidity situation, on the price high, a large variety of discount space, in accordance with the principles of a positive step and secure lower prices; on clinical need low cost, the exact efficacy of drugs will not cut prices to encourage the production of cheap drugs, operation and use; on the market, short supply or out of supplies of varieties appropriate to raise prices. Directory from the price adjustment related to the anti-diabetic proprietary price adjustment has been evident.
List price adjustment, a total of more than 10 proprietary Chinese medicines, anti-diabetes product regulation, including the "National Basic Medical Insurance Drug List" in the two Group A drugs, 5 B drugs. Comparative analysis of the market retail price, hypoglycemic drugs category general decline in the highest 38%, the average reduction of 20.29%. While two species are listed as species at competitive prices, price increases were modest, that is one of Guangzhou's Xiaoke Pill and Lunan Pharmaceutical & P Pharmaceutical Co., Ltd. thick Shenqijiangtang powder (sugar free) (see Schedule).
R & D triumph Recent years, mushrooming of anti-diabetic drugs such as emerging. According to the State Food and Drug Administration Southern Medical Economic Institute statistics show that domestic anti-diabetic drugs in 2005 has reached 60 billion, is expected to reach 7.0 billion in 2006.
Anti-diabetic drug market growth continues unabated main factor is in addition to large consumer groups, the manufacturers and hospitals driven by the interests of the clinical use of too many expensive new drugs and insulin also stimulate the growth of consumption.
Present, the domestic market, the Western hypoglycemic drugs accounted for 80% of the share, while the share of proprietary small, only 20%. Although the anti-diabetic agents through clinical application of Chinese medicine have shown that those low on glucose tolerance, mild diabetes treatment has been fully affirmed and known to have hypoglycemic effect of traditional Chinese medicine has more than 100 species, "Chinese Pharmacopoeia "It has been collected 40 kinds of drugs are used in the clinic, and some have been widely used to treat diabetes. Which is effective, good market prospects, the production has not expanded the scope of the 18 species has been declared a national TCM protection. But more than individual species behave well, the market has not emerged, "blockbuster" level product.
90 years since the last century, the country's rapid development of hypoglycemic agents of proprietary Chinese medicines. At present, the popular Chinese medicine preparations and compound preparations are about more than 10. According to incomplete statistics, Xiaoke Pill, Tangmaikang, Diabetes Health, Sugar Music, Magnolia hypoglycemic capsules, Yu Ling Diabetes is the 6 exclusive varieties of tea. The hypoglycemic Shu, thirsty music Ning, Yu Quan Wan (tablets, powder, granule), 10 Yuquan flavor capsules Shenqijiangtang, vibration source capsules (oral solution, tablets) approved for production in various varieties were 10 manufacturers of inside; Jiangtangning, production approval xiaokeling up more than 50; hypoglycemic agents proprietary production approval for more than 200.
Oral hypoglycemic medicine from the market in 2005 terms, the list are varieties Xiaoke Pill, Tangmaikang particles Shenqijiangtang particles, diabetes capsules, Jinqi metformin, Yuquan Pill, thirsty music Ning, Yu Ye Diabetes particles. Which has occupied the proprietary Xiaoke wan half of the market, only 45% of other varieties.
I am China Hardware Suppliers writer, reports some information about facial gel mask , magnetic face mask.
Processing your request, Please wait....
